Search Results

There are 8183 results for: content related to: Superior outcome with hypomethylating therapy in patients with acute myeloid leukemia and high-risk myelodysplastic syndrome and chromosome 5 and 7 abnormalities

  1. Clofarabine in pediatric acute leukemia: Current findings and issues

    Pediatric Blood & Cancer

    Volume 59, Issue 3, September 2012, Pages: 417–422, Nobuko Hijiya, Elly Barry and Robert J. Arceci

    Version of Record online : 21 FEB 2012, DOI: 10.1002/pbc.24112

  2. Pharmacokinetics of Clofarabine in Patients With High-Risk Inherited Metabolic Disorders Undergoing Brain-Sparing Hematopoietic Cell Transplantation

    The Journal of Clinical Pharmacology

    Volume 51, Issue 5, May 2011, Pages: 679–686, Dr Janel Long-Boyle, Dr Jiayin Huang, Dr Nancy Rydholm, Dr Angela Smith, Dr Paul Orchard, Dr Jakub Tolar and Dr Pamala Jacobson

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270010372519

  3. Population Pharmacokinetics of Clofarabine, a Second-Generation Nucleoside Analog, in Pediatric Patients With Acute Leukemia

    The Journal of Clinical Pharmacology

    Volume 44, Issue 11, November 2004, Pages: 1309–1322, Dr Peter L. Bonate, Dr Adam Craig, Dr Paul Gaynon, Dr Varsha Gandhi, Dr Sima Jeha, Dr Richard Kadota, Dr Gilbert N. Lam, Dr William Plunkett, Dr Bassem Razzouk, Dr Michael Rytting, Dr Peter Steinherz and Dr Steve Weitman

    Version of Record online : 8 MAR 2013, DOI: 10.1177/0091270004269236

  4. Valproic acid synergistically enhances the cytotoxicity of clofarabine in pediatric acute myeloid leukemia cells

    Pediatric Blood & Cancer

    Volume 59, Issue 7, 15 December 2012, Pages: 1245–1251, Chengzhi Xie, Holly Edwards, Salvatore B. LoGrasso, Steven A. Buck, Larry H. Matherly, Jeffrey W. Taub and Yubin Ge

    Version of Record online : 5 APR 2012, DOI: 10.1002/pbc.24152

  5. You have free access to this content
    G-CSF Priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm

    American Journal of Hematology

    Volume 90, Issue 4, April 2015, Pages: 295–300, Pamela S. Becker, Bruno C. Medeiros, Anthony S. Stein, Megan Othus, Frederick R. Appelbaum, Stephen J. Forman, Bart L. Scott, Paul C. Hendrie, Kelda M. Gardner, John M. Pagel, Roland B. Walter, Cynthia Parks, Brent L. Wood, Janis L. Abkowitz and Elihu H. Estey

    Version of Record online : 30 JAN 2015, DOI: 10.1002/ajh.23927

  6. You have free access to this content
    The role of clofarabine in hematologic and solid malignancies—Development of a next-generation nucleoside analog

    Cancer

    Volume 103, Issue 10, 15 May 2005, Pages: 1985–1995, Stefan Faderl, Varsha Gandhi, Michael J. Keating, Sima Jeha, William Plunkett and Hagop M. Kantarjian

    Version of Record online : 31 MAR 2005, DOI: 10.1002/cncr.21005

  7. Effect of hemodialysis on the plasma levels of clofarabine

    Pediatric Blood & Cancer

    Volume 55, Issue 1, 15 July 2010, Pages: 196–198, Peter G. Steinherz, Neerav Shukla, Rachel Kobos and Sheron Latcha

    Version of Record online : 15 MAR 2010, DOI: 10.1002/pbc.22458

  8. You have free access to this content
    Final results of a phase 2 trial of clofarabine and low-dose cytarabine alternating with decitabine in older patients with newly diagnosed acute myeloid leukemia

    Cancer

    Volume 121, Issue 14, July 15 2015, Pages: 2375–2382, Tapan M. Kadia, Stefan Faderl, Farhad Ravandi, Elias Jabbour, Guillermo Garcia-Manero, Gautam Borthakur, Alessandra Ferrajoli, Marina Konopleva, Jan Burger, Xuelin Huang, Xuemei Wang, Sherry Pierce, Mark Brandt, Jennie Feliu, Jorge Cortes and Hagop Kantarjian

    Version of Record online : 25 MAR 2015, DOI: 10.1002/cncr.29367

  9. You have free access to this content
    Clofarabine-based chemotherapy for relapsed/refractory adult acute lymphoblastic leukemia and lymphoblastic lymphoma. The Spanish experience

    American Journal of Hematology

    Volume 87, Issue 6, June 2012, Pages: 631–634, Pere Barba, Antonia Sampol, María Calbacho, José Gonzalez, Josefina Serrano, Pilar Martínez-Sánchez, Pascual Fernández, Raimundo García-Boyero, Javier Bueno, Josep Maria Ribera and On behalf of the Programa para el Estudio y Tratamiento de las Hemopatías Malignas (PETHEMA) group. www.pethema.org

    Version of Record online : 19 MAR 2012, DOI: 10.1002/ajh.23167

  10. You have free access to this content
    Clofarabine

    Cancer

    Volume 113, Issue 8, 15 October 2008, Pages: 1995–1998, Pellegrino Musto and Felicetto Ferrara

    Version of Record online : 8 SEP 2008, DOI: 10.1002/cncr.23804

  11. Conventional chemotherapy or hypomethylating agents for older patients with acute myeloid leukaemia?

    Hematological Oncology

    Volume 32, Issue 1, March 2014, Pages: 1–9, Felicetto Ferrara

    Version of Record online : 20 MAR 2013, DOI: 10.1002/hon.2046

  12. SIOP 2015 Scientific Programme + Index

    Pediatric Blood & Cancer

    Volume 62, Issue S4, November 2015, Pages: S143–S418,

    Version of Record online : 9 SEP 2015, DOI: 10.1002/pbc.25715

  13. You have free access to this content
    Clofarabine in combination with pegylated asparaginase in the frontline treatment of childhood acute lymphoblastic leukaemia: a feasibility report from the CoALL 08-09 trial

    British Journal of Haematology

    Volume 163, Issue 2, October 2013, Pages: 240–247, Gabriele Escherich, Udo zur Stadt, Martin Zimmermann, Martin A. Horstmann and on behalf of the CoALL study group

    Version of Record online : 12 AUG 2013, DOI: 10.1111/bjh.12520

  14. Clofarabine in the treatment of poor risk acute myeloid leukaemia

    Hematological Oncology

    Volume 28, Issue 3, September 2010, Pages: 118–123, Janusz Krawczyk, Naeem Ansar, Ronan Swords, Tracy Murphy, Barry MacDonagh, Teresa Meenaghan, Patrick Hayden, Amjad Hayad, Margaret Murray and Michael O'Dwyer

    Version of Record online : 18 SEP 2009, DOI: 10.1002/hon.922

  15. Clofarabine salvage therapy for refractory high-risk langerhans cell histiocytosis

    Pediatric Blood & Cancer

    Volume 60, Issue 6, June 2013, Pages: E19–E22, Allistair Abraham, Abdulrahman Alsultan, Michael Jeng, Carlos Rodriguez-Galindo and Patrick K. Campbell

    Version of Record online : 19 DEC 2012, DOI: 10.1002/pbc.24436

  16. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhans cell histiocytosis, juvenile xanthogranuloma and Rosai–Dorfman disease

    Pediatric Blood & Cancer

    Volume 61, Issue 3, March 2014, Pages: 479–487, Stephen J. Simko, Huy D. Tran, Jeremy Jones, Mrinalini Bilgi, Lynda Kwon Beaupin, Don Coulter, Timothy Garrington, Timothy L. McCavit, Colin Moore, Francisco Rivera-Ortegón, Linda Shaffer, Linda Stork, Lucie Turcotte, Esperanza C. Welsh, M. John Hicks, Kenneth L. McClain and Carl E. Allen

    Version of Record online : 18 SEP 2013, DOI: 10.1002/pbc.24772

  17. You have free access to this content
    Early UK experience in the use of clofarabine in the treatment of relapsed and refractory paediatric acute lymphoblastic leukaemia

    British Journal of Haematology

    Volume 154, Issue 4, August 2011, Pages: 482–485, David O’Connor, Keith Sibson, Mark Caswell, Philip Connor, Michelle Cummins, Chris Mitchell, Jayashree Motwani, Mary Taj, Ajay Vora, Robert Wynn and Pamela R. Kearns

    Version of Record online : 21 JUN 2011, DOI: 10.1111/j.1365-2141.2011.08752.x

  18. You have free access to this content
    A randomized study of 2 dose levels of intravenous clofarabine in the treatment of patients with higher-risk myelodysplastic syndrome

    Cancer

    Volume 118, Issue 3, 1 February 2012, Pages: 722–728, Stefan Faderl, Guillermo Garcia-Manero, Elias Jabbour, Farhad Ravandi, Gautam Borthakur, Zeev Estrov, Varsha Gandhi, Anna L. Byrd, Monica Kwari, Jorge Cortes and Hagop M. Kantarjian

    Version of Record online : 12 JUL 2011, DOI: 10.1002/cncr.26327

  19. You have free access to this content
    Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients

    Cancer

    Volume 118, Issue 18, 15 September 2012, Pages: 4471–4477, Stefan Faderl, Farhad Ravandi, Xuelin Huang, Xuemei Wang, Elias Jabbour, Guillermo Garcia-Manero, Tapan Kadia, Alessandra Ferrajoli, Marina Konopleva, Gautam Borthakur, Jan Burger, Jennie Feliu and Hagop M. Kantarjian

    Version of Record online : 26 JAN 2012, DOI: 10.1002/cncr.27429

  20. You have free access to this content
    Phase I study of oral clofarabine consolidation in adults aged 60 and older with acute myeloid leukemia

    American Journal of Hematology

    Volume 89, Issue 5, May 2014, Pages: 487–492, Meagan A. Jacoby, Michael G. Martin, Geoffrey L. Uy, Peter Westervelt, John F. DiPersio, Amanda Cashen, Keith Stockerl-Goldstein, Ravi Vij, Jingqin Luo, Teresa Reineck, Noel Bernabe and Camille N. Abboud

    Version of Record online : 3 MAR 2014, DOI: 10.1002/ajh.23663